• Facebook
  • Twitter
  • LinkedIn
  • Google +
  • RSS

Pharma news

The latest news from the pharmaceutical industry and suppliers. If you have a piece of news that you would like us to cover, please contact Victoria White on +44 (0)1959 563311 or email us.

 

EC grants Orphan Drug Designation to SGX301

Posted on: 4 August 2015

The EC has granted orphan drug designation to Solgenix’s synthetic hypericin (the active ingredient in SGX301) for the treatment of cutaneous T-cell lymphoma...

Shire makes unsolicited bid to buy Baxalta

Posted on: 4 August 2015

Shire made a proposal to Baxalta on 10 July 2015 to combine the companies in an all-stock transaction worth approximately $30.6 billion...

Sanofi’s Toujeo now available in the UK

Posted on: 4 August 2015

Toujeo is now available in the UK, providing another option for adults with type 1 and type 2 diabetes mellitus to help manage their condition...

FDA approves first ever 3D printed drug product: Spritam

Posted on: 4 August 2015

The FDA has approved 3D printed drug Spritam for the treatment of of partial onset seizures, myoclonic seizures and generalised tonic-clonic seizures...

Pfizer and Synthon enter commercialisation agreement

Posted on: 4 August 2015

Pfizer and Synthon have entered into an agreement whereby Pfizer has acquired the exclusive commercialisation rights in the US to glatiramer acetate...

FDA accepts Mundipharma EDO’s IND for EDO-S101

Posted on: 3 August 2015

The FDA has accepted Mundipharma EDO’s IND for EDO-S101, a fusion molecule to treat relapsed/refractory haematologic malignancies and solid tumours...

Shire adds FST-100 to pipeline with Foresight acquisition

Posted on: 3 August 2015

Shire has acquired Foresight Biotherapeutics, gaining global rights to FST-100 - a therapy in development for the treatment of infectious conjunctivitis...

Celyad completes final patient infusion in Phase III trial of C-Cure

Posted on: 3 August 2015

Celyad has completed the injection procedure for the last patient enrolled in CHART-1, its Phase III clinical trial of cardiovascular candidate, C-Cure...

Cell Therapy Catapult awards major contract to CTL

Posted on: 3 August 2015

Cell Therapy Catapult has awarded a contract to CTL to accelerate its clinical programme to develop an engineered T cell treatment for blood cancers...

Hope for pancreatic cancer urine test

Posted on: 3 August 2015

A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers have found...

Positive top-line results for Phase 3 telotristat etiprate study

Posted on: 3 August 2015

A Phase 3 clinical trial met its primary endpoint, showing the benefit of oral telotristat etiprate in treating cancer patients with carcinoid syndrome...

World’s first international pharmaceutical seminar on Transmission Raman Spectroscopy

Posted on: 31 July 2015

Cobalt is hosting the first ever seminar on the use of Transmission Raman Spectroscopy (TRS) in quantitative pharmaceutical analysis...

 

 

Webinar: Increasing throughput and sensitivity of LC-MS assaysWATCH NOW
+